title: Shake Up in the Neostig- mine Methylsulfate Cholin- esterase Inhibitor Market for Neuromuscular Block Reversal.
authors.forename: Mark
authors.initials: M
authors.lastname: Welliver
mesh_terms: D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000191:economics*; D003365:Costs and Cost Analysis / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000191:economics*; D006801:Humans; D008389:Marketing of Health Services; D009388:Neostigmine / Q000008:administration & dosage / Q000191:economics*; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors* / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D002800:Cholinesterase Inhibitors; D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine